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ABSTRACT Contact tracing requires reliable identiﬁcation of closely related bacte-
rial isolates. When we noticed the reporting of artifactual variation between Myco-
bacterium tuberculosis isolates during routine next-generation sequencing of Myco-
bacterium spp., we investigated its basis in 2,018 consecutive M. tuberculosis isolates.
In the routine process used, clinical samples were decontaminated and inoculated
into broth cultures; from positive broth cultures DNA was extracted and sequenced,
reads were mapped, and consensus sequences were determined. We investigated
the process of consensus sequence determination, which selects the most common
nucleotide at each position. Having determined the high-quality read depth and
depth of minor variants across 8,006 M. tuberculosis genomic regions, we quantiﬁed
the relationship between the minor variant depth and the amount of nonmycobac-
terial bacterial DNA, which originates from commensal microbes killed during sam-
ple decontamination. In the presence of nonmycobacterial bacterial DNA, we found
signiﬁcant increases in minor variant frequencies, of more than 1.5-fold, in 242 re-
gions covering 5.1% of the M. tuberculosis genome. Included within these were four
high-variation regions strongly inﬂuenced by the amount of nonmycobacterial bac-
terial DNA. Excluding these four regions from pairwise distance comparisons re-
duced biologically implausible variation from 5.2% to 0% in an independent vali-
dation set derived from 226 individuals. Thus, we demonstrated an approach
identifying critical genomic regions contributing to clinically relevant artifactual
variation in bacterial similarity searches. The approach described monitors the out-
puts of the complex multistep laboratory and bioinformatics process, allows periodic
process adjustments, and will have application to quality control of routine bacterial
genomics.
KEYWORDS artifact, Mycobacterium tuberculosis, reference mapping, relatedness,
single nucleotide variation
Identifying closely related bacterial isolates is required for clinical and epidemiologicalpurposes (1–3). Most published approaches using short-read next-generation se-
quencing (NGS) rely on mapping to a high-quality reference sequence followed by
consensus base calling (1–8). A known problem with this approach concerns the
existence in many bacterial genomes of “hard-to-map” regions which either are re-
peated within the genome or contain regions of low sequence complexity. High-
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conﬁdence mapping of short reads to such regions is difﬁcult or impossible, and so
determining the consensus sequence of these regions is difﬁcult. One approach to
managing this problem is to identify these regions bioinformatically prior to mapping
by analysis of sequence complexity (9) or from repetitiveness within the genome (10).
Base calls within these prespeciﬁed regions are then ignored (“masking”) when assess-
ing relatedness of isolate sequences. A second complementary approach ﬁlters base
calls based on read mapping conﬁdence as reported by various mappers (11–14) in the
form of mapping quality (MAQ) scores.
Mycobacterium tuberculosis is one of the most important pathogens of humans, with
about 3 million cases of tuberculosis (TB) conﬁrmed by culture globally each year (15).
Recently, laboratory protocols have been described and deployed by Public Health
England (4) in which the species and drug resistance of mycobacteria, including M.
tuberculosis, are identiﬁed by sequencing microbial DNA. Laboratory processing of
clinical samples suspected of containing mycobacteria involves decontamination using
chemicals which kill nonmycobacterial species before the samples are inoculated into
broth culture (16). Mycobacterial growth indicator tubes (MGITs) and associated tube
monitoring equipment are a commercially available implementation of such a broth
culture system.
In the process adopted by Public Health England, sequencing and bioinformatics
analysis of DNA extracted from positive MGITs allows determination of mycobacterial
species and drug resistance (17). This laboratory and bioinformatics process also allows
the genetic distance between M. tuberculosis isolates to be estimated, using sequences
derived by consensus base calling from mapped data. The organism coevolved with
human populations as they migrated, generating multiple lineages which differ from
the ancestral sequence by hundreds or thousands of single nucleotide polymorphisms
(SNPs) (18), as well as small indels, gene deletions, and inversions (19). However, the
evolutionary clock rate of the organism is slow, at about 0.5 single nucleotide variant
(SNV)/genome/annum (3, 5, 7), and small numbers of SNVs are of clinical signiﬁcance:
studies based on retrospective collections of M. tuberculosis organisms grown on solid
media prior to sequencing have proposed a threshold of 5 SNVs as compatible with
recent transmission (3, 5, 7). The bioinformatics processes used for relatedness estima-
tion in the deployed pipeline were also optimized using samples regrown from frozen
stocks on solid media (Lowenstein-Jensen slopes) (16).
The quality of complex processes deployed in medical laboratories is ensured by
adherence to quality standards, such as those laid out in ISO15189:2012 (20). These
standards require that the processes followed and the environments in which they
operate comply with patterns of work known to enhance the consistency and inter-
pretability of the laboratory outputs. For example, in a drug testing laboratory, a set of
samples of known composition may be run through the analyzers to conﬁrm that
particular commonly found substances which might potentially interfere with the assay
(such as caffeine and paracetamol) have no impact on detection of the drug of interest.
M. tuberculosis infection is commonly diagnosed from sputum samples, which contain
a wide variety of organisms other than mycobacteria (21). DNA from such organisms
may contain sequences homologous with those present in mycobacteria, for example,
in highly conserved core bacterial genes. Therefore, this nonmycobacterial DNA has the
potential to interfere with assays based on mapping of mycobacterial reference ge-
nome mapping.
In this study, we investigated the concept of interfering substances in the context
of the detection of closely related M. tuberculosis isolates. In particular, we considered
whether DNA of nonmycobacterial origin might cause interference. We describe a
process which we call adaptive masking. This deﬁnes hard-to-map regions existing in
the context of the laboratory, sequencing, and mapping processes being used, inde-
pendently of predictions based on the reference sequence and of ﬁltering based on
reported mapping quality. Our work was motivated in part by observations from
analysis of prospective sequencing of M. tuberculosis sequences in England using a
previously described bioinformatics pipeline (17). It appeared that large SNV distances
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were being reported between isolates with a strong epidemiological likelihood of
having recently transmitted to each (e.g., isolates with unusual resistance proﬁles from
individuals who were cohabiting): that is, false-positive variation between isolates was
being reported. We assess the impact of adaptive masking on addressing this problem
and discuss quality control of relatedness monitoring in the context of continuous
process monitoring in accredited clinical laboratories.
MATERIALS AND METHODS
Isolation of DNA from mycobacteria and sequencing. Clinical specimens were decontaminated
and inoculated into mycobacterial growth indicator tubes (MGITs) (16). Positive samples were extracted
(4). After DNA extraction, Illumina sequencing libraries were prepared using either 11 (early in the study)
or 15 (later in the study) mycobacterial DNA extracts, as previously described (4). All samples sent from
patients for processing for mycobacteria between 1 May 2016 and 30 May 2017 to a single reference
laboratory were studied; the catchment of this laboratory is approximately 15 million people, or about
one-third the population of England.
Bioinformatics processing. Reads obtained from the MiSeq instrument were ﬁrst examined for the
presence of Mycobacterium tuberculosis using the Mykrobe tool, which detects species-speciﬁc k-mers
(22). Only samples identiﬁed as being derived from the M. tuberculosis complex by Mykrobe (22) were
considered in this work. Additional read classiﬁcation was performed with Kraken (23), which assigned
reads to bespoke database constructed from (i) all bacterial genomes deposited in the NCBI RefSeq
database as of January 2017 and (ii) Genome Reference Consortium Human Build 38 (GRCh38) to allow
detection of host DNA as described previously (24), but with k-mer reduction to 25 Gb. We quantiﬁed
reads mapped to M. tuberculosis (NCBI taxonomy identiﬁer: 77643), to nonmycobacterial bacterial
species, and to humans. After this, human reads were discarded.
Reads were mapped to the H37Rv v2 genome (GenBank accession number NC_000962.2) using
Stampy (14), as described previously (4). Samtools (25) was used to assess sequencing and mapping
quality: high-quality bases were considered to be those passing the q30 and Q30 30 ﬁlters (read
quality and mapping quality all 30). Consensus sequence was called, requiring a minimum read depth
of 5, including at least 1 read on each strand. Where an alternative base represented more than 10% of
read depth, the base was recorded as uncertain, as described previously (26).
The variant call format (VCF) ﬁle was parsed with custom python scripts, and the number of
high-quality bases (deﬁned using the ﬁlters above) at each position was determined. These frequencies
were extracted, stored, and indexed using SQLite with a python API constructed to allow extraction of
mixture frequencies in arbitrary positions.
Modeling minor variant frequencies. We determined the most common (major) variant at each
position. All other variants are considered minor variants. We deﬁne n as the total sequencing depth at
one base, m as the depth of most common variant at one base, and m= as the depth of all variants other
than most common, n  m (see Fig. S1 in the supplemental material).
We divided up the H37Rv genome based on the annotation in NC_000962.3, identifying 8,007
regions R, comprising open reading frames and regions between open reading frames (Data Set S1 in the
supplemental material).
For each of these regions j  1.0.8007, if the region has length lj, the total number of minor variant
bases Vj across the i  1. . .lj bases in the region is given by equation 1 and the total read depth Dj across
the gene by equation 2.
Vj
i1
l
m'l (1)
Dj
i1
l
nl (2)
In order to describe the relationship between nonmycobacterial DNA quantiﬁcations and minor allele
frequency, we stratiﬁed the number of reads from each sample identiﬁed as being from bacterial genera
other than Mycobacterium (b) into four approximately equal-size strata: b  1%, 1%  b  5%, 5% 
b  20%, and b  20%.
We constructed separate Poisson regression models relating minor base counts (V) for each of the
8,007 regions [with log link and offset log(D)] to the nonmycobacterial bacterial read categories b
(reference category  1%), excluding any samples with zero high-quality depth in that region. We
applied Bonferroni correction to model outputs to control for multiple testing (  0.01/8,007  1.2 
106).
Comparing impact of masking on pairwise comparisons. Based on analysis of model output (see
Results), regions with higher minor variant counts than expected were identiﬁed. These regions were
excluded from pairwise comparisons performed using the ﬁndNeighbour2 tool (27).
Impact of mapper. For a random 250-sample subset, we compared the impacts of different mappers
on minor variant frequencies across regions using the pipeline described above. We compared mapping
with Stampy 1.0.32 (14), and Bowtie v 1.2.2 (11) with default parameters, and Bowtie2 v 2.3.4.1 with
–very-sensitive and –very-fast preset parameters (28).
Ethical framework. Public health action taken as a result of notiﬁcation and surveillance is one of
the Public Health England’s key roles as stated in the Health and Social Care Act 2012 and subsequent
government directives which provide the mandate and legislative basis to undertake necessary follow-
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up. Part of this follow-up is identiﬁcation of epidemiological and molecular links between cases. This
work is part of service development carried out under this framework, and therefore, explicit ethical
approval is unnecessary.
Availability of data. The identiﬁers for the samples studied are in the supplemental material, and
the raw sequence data are in the NCBI under project number PRJNA302362. Software to effect the
process described, test data, links to the data used, and documentation is freely available at https://
github.com/davidhwyllie/adaptivemasking.
RESULTS
Samples studied. The PHE National Mycobacteriology Reference Laboratory Mid-
lands implemented a laboratory process in which specimens received are decontami-
nated and inoculated into MGIT bottles, DNA extracts from positive MGIT bottles are
made, and their contents are determined using Illumina short-read sequencing (17).
Using this process, in the 13 months from 1 May 2016 to 30 May 2017, M. tuberculosis
was identiﬁed in 2,751 samples sent from 2,252 patients (Fig. 1). Using these samples,
we derived and validated using an independent validation set (Fig. 1) a strategy for
investigating and controlling false-positive variation between samples, which we here
term adaptive masking (Fig. 2). The initial stages of adaptive masking involve estimat-
ing minor variant frequencies across the genome from mapped data and determining
whether these are related to the amount of nonmycobacterial DNA present.
We identiﬁed 718 samples from 234 individuals from whom more than one positive
sample had been obtained with 7 days of another. Of these, for six individuals samples
were reported as either being of different lineages, as deﬁned previously (29), differing
in multiple drug resistances, or differing by400 high-quality SNVs. These observations
we considered likely due to laboratory or sampling mix-ups, and samples from these
patients were excluded. The other 700 samples were used as an independent validation
set. From remaining samples, we identiﬁed the ﬁrst sample from each of 2,018
individuals which were used to develop the adaptive-masking strategy (Fig. 1).
Quantifying extraneous DNA and minor variant frequencies postmapping. We
determined the proportion of nonmycobacterial bacterial DNA in each sample using
Kraken (23), mapped all reads to the H37Rv reference genome irrespective of Kraken
results, and ﬁltered the mapped data using stringent quality ﬁlters such that the
expected error rate is less than 103 (see Materials and Methods). We deﬁned 8,007
genomic regions in the reference genome; these regions comprise all canonical open
reading frames and the genomic regions between them (Data Set S1). We were unable
FIG 1 Samples used and derivation and validation sets. Shown is a ﬂowchart describing the samples used and the
selection of derivation and validation sets.
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to assess one 15-nucleotide (nt) region between two PPE family members (positions
3380439 to 3380453), as no high-quality data mapped there in any sample.
In the other 8,006 regions, we observed that both minor variant frequencies and the
relationship between minor variant frequency and the number of reads of nonmyco-
bacterial origin differed markedly by gene. For example, the B55 and esxW genes had,
respectively, very low and very high minor variant frequencies, independent of non-
mycobacterial DNA quantity. A small group of genes, of which the ribosomal compo-
FIG 2 Bioinformatics processes. Shown is a ﬂow diagram illustrating the standard bioinformatics pipeline used, as well as the
adaptive-masking process used to generate masks. Gray circles indicate links to a description of the process at https://github
.com/davidhwyllie/adaptivemasking. ﬁndNeighbour2 is an open-source server-based system for monitoring single nucleotide
variation (27).
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nent rrs is an example, showed low minor variant frequencies, except when nonmy-
cobacterial DNA was present (Fig. 3).
Estimating the impact of extraneous bacterial DNA.Wemodeled the relationship
between minor variant counts and the number of nonmycobacterial reads, divided into
four approximately equal-size strata (Fig. 3B), using Poisson models (Data Set S2).
Separate models were constructed for each region. Estimated minor variant frequencies
in samples with 1% nonmycobacterial bacterial reads had a median of 5  104 (Fig.
4A) across the 8,006 genomic regions, which is compatible with the expected mapping
error rate of 103, given the ﬁlters applied.
FIG 3 Minor variant frequency and nonmycobacterial bacterial DNA quantities. The observed minor variant
frequency for three regions of the M. tuberculosis genome (genes B55, eswX, and rrs) versus the proportion of reads
of nonmycobacterial bacterial origin (as determined by Kraken) is shown for samples in the derivation set (n 
2,018). Panel A shows a dot plot, whereas in panel B, the proportion of reads of nonmycobacterial bacterial origin
is stratiﬁed with 1%, 5%, and 20% boundaries. The number at each stratum refers to the number of samples with
nonzero read depth in that region.
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FIG 4 Modeling minor variant frequencies. For 8,006 genomic regions of the H37Rv reference
genome, Poisson models were used to estimate the mean minor variant frequency. The estimated
minor variant frequency when less than 1% nonmycobacterial bacterial DNA is present (n  208
[2.6% of the regions]) is shown in panel A. The red line is a lognormal distribution with  
log(minor variant frequency with 1% nonmycobacterial DNA) and   median absolute deviation
[log(minor variant frequency with 1% nonmycobacterial DNA)]. In panel B the rate ratio estimates
(i.e., the fold change associated with increases in nonmycobacterial bacterial DNA quantiﬁcations)
for each gene are shown. Panel C shows the signiﬁcance of a test comparing the log(rate ratio
estimates) with zero, in the form of a Volcano plot. The dashed lines in panels B and C correspond
to a 50% increase in rate ratio.
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The distribution of minor variant frequencies when less than 1% nonmycobacterial
bacterial DNA was present approximated a lognormal distribution with mean log(5 
104) and standard deviation equal to the median absolute deviation (Fig. 4A, ob-
served, black line, and ﬁtted, red line), but with a tail to the right. A total of 208 regions
(2.6% of the total 8,006 regions), including esxW as well as other esx and PPE family
members, had estimated minor variant frequencies of 2.1  103 when 1%
nonmycobacterial bacterial reads were present (Fig. 4A; see also Data Set S2). This
cutoff represents four median absolute deviations above the median; if the data were
lognormally distributed, 24 samples would be expected with minor variant frequencies
greater than this, versus the 208 observed.
Overall, estimated minor variant counts rose as nonmycobacterial DNA concentra-
tion rose, but for most regions the increase was small (Fig. 4B): the median fold change
in minor variant counts in the presence of 20% nonmycobacterial DNA versus 1%
nonmycobacterial DNA was 1.097 (i.e., a 9.7% increase; interquartile range, 5.4% to
14.0%). A total of 242 regions (3.0%) had statistically signiﬁcant increases (Fig. 4B and
C), more than 50%. Most of these regions had the highest minor variant counts when
20% nonmycobacterial DNA was present, although a small number had similar minor
variant counts, in the 5 to 20% range and the 20% range (Fig. S2B).
Mutually exclusive regions with increased minor variant frequency. Comparing
regions with increased minor variant rates with low (1%) nonmycobacterial bacterial
DNA with those with increased minor variant rates with high (20%) nonmycobacterial
bacterial DNA shows these regions to be mutually exclusive (Fig. 5). The former include
PPE and esx family members, while the latter include ribosomal components (rrl, rrs,
rplB, and rps genes) as well as other highly conserved bacterial genes (tRNA genes,
fusA1, infA, dnaK, and others) (Fig. 5; see also Data Set S2).
Examining Kraken read assignments in reads mapped to these highly conserved
genes indicated that many reads mapping to these highly conserved regions cannot be
unambiguously assigned to the M. tuberculosis taxon (Fig. S3) even when nonmyco-
bacterial bacterial DNA is not present or is present in small amounts. For example, in
the 422 samples for which1% of total bacterial DNA is nonmycobacterial, only a small
proportion (27.3%) of reads mapping with high quality to rrs are assigned to the
Mycobacterium genus by Kraken. However, since very little, if any, nonmycobacterial
bacterial DNA is present, these reads are almost certainly derived from M. tuberculosis
rrs. In contrast, the corresponding ﬁgure for a gene with little homology with nonmy-
cobacterial genomes (B55) is 97.4%. The corollary is that if one routinely removes reads
which are not assigned by Kraken to the genus of interest (in this case Mycobacterium),
one will remove a very high proportion of the reads corresponding to critical loci
(including drug targets, such as rrs), even when no nonmycobacterial bacterial DNA is
present, as occurs if one is sequencing pure cultures.
Adaptive masking reduces the reporting of biologically implausible interindi-
vidual variation. A published strategy for excluding regions of high mapping variation
within the M. tuberculosis genome strategy masks (i.e., excludes from relatedness
computations) 277,709 nt (6.3%) of the genome (4). Excluding regions with high
estimated minor variant counts with 1% nonmycobacterial DNA (zone A in Fig. 5B)
adds an additional 1.1%. Excluding regions with increased estimated minor variant
counts only in the presence of 20% nonmycobacterial bacterial DNA (zones B to D)
masks between 0.2% and 5.1% extra (Fig. 5B and C). The masking of regions identiﬁed
by “adapting” to variation generated during the process forms the ﬁnal part of the
adaptive masking process.
In a validation set comprising isolates taken with 7 days of each other from 234
individuals, using the published strategy, 18/346 (5.2%) pairs studied had 5 SNVs;
10 of these had 20 SNVs. On exclusion of region D, which comprises the four genes
most inﬂuenced by nonmycobacterial DNA, all encoding ribosome-associated products (the
genes rrl and rrs, together with the tRNA metU and the highly conserved bacterial gene
tuf), 0/346 pairs differed by 5 SNP (P 104 compared with the published method,
Wyllie et al. Journal of Clinical Microbiology
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Wilcoxon test on pairs). These genes were the only genes with minor variant frequen-
cies signiﬁcantly affected by nonmycobacterial DNA, i.e., at the 1 to 5% level (Fig. 4B,
top portion; see also Data Set S2). Additional exclusion of genes in regions B and C,
mapping to which is less inﬂuenced by nonmycobacterial DNA, had a limited impact
(Fig. 6).
FIG 5 A distinct subset of genes are impacted by quantity of nonmycobacterial DNA. (A) Fold change in minor variant frequency with
20% nonmycobacterial bacterial DNA present versus 1% nonmycobacterial bacterial DNA. Quadrant boundary markers correspond to
(horizontal line) a 50% increase over 1% nonmycobacterial bacterial DNA and (vertical line) a minor variant frequency of 2.1  103.
(B) Genes with elevated minor variant frequencies when nonmycobacterial bacterial DNA is low (1%) or high (20%) fall into mutually
exclusive sets. (C) The number of bases represented by the deployed masking versus the deployed masking plus the genes in zones A,
A plus D, A plus D plus C, and A plus D plus C plus B.
Artifactual Variation between M. tuberculosis Isolates Journal of Clinical Microbiology
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Impact of mapper. In the above-described work, we use the Stampy mapper (14)
which forms part of the deployed TB bioinformatics pipeline (17). To determine
whether the choice of mapper was important, we compared the results of mapping a
250-sample test set to the H37Rv reference genome using four different software/
parameter settings. We identiﬁed regions with any signiﬁcantly increased mixture
FIG 6 Impact of masking strategies on reported distances between closely related samples. SNV distances between pairs of
M. tuberculosis genomes isolates from samples taken from the same individual within 7 days of each other were compared
using different masking strategies. The top portion describes the published, deployed method of masking. In the panels below
that, genes in the zones shown in Fig. 5B are additionally masked (i.e., ignored from pairwise comparisons).
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frequencies when20% nonmycobacterial bacterial DNA was present relative to when
1% was present using a P value of 0.05, adjusted by Bonferroni’s method to 7.6 
106. The numbers of such regions detected with Stampy, bowtie, and bowtie2 with
stringent matching criteria and with bowtie2 with more relaxed matching criteria were
2,544, 25, 70, and 72, respectively (Data Set S3). Increases in minor variant frequencies
in rrl were detected by all techniques; estimated fold increases in minor variant
frequencies associated with 20% nonmycobacterial bacterial DNA were 37, 1.4, 1.5,
and 1.5, respectively. Thus, although the mismapping observed identiﬁed occurred in
all cases examined, it was much more prominent with Stampy than with the bowtie
series of mappers.
DISCUSSION
Here we describe an approach which we term adaptive masking. This involves
monitoring the minor variant frequency across a bacterial genome to which sequenc-
ing reads have been mapped; consequently, it measures an end product of next-
generation sequencing processes, taking into account the natural sequence variation in
the samples studied as well as the impact of DNA extraction and library construction
technologies and the performance of the mapping and ﬁltering software used.
Using this approach, we deﬁned a set of hard-to-map genetic regions (Fig. 5, zone
A) with increased minor variant frequencies irrespective of the amount of nonmyco-
bacterial bacterial DNA. Exclusion of these regions could be considered when assessing
consensus M. tuberculosis sequences.
We also demonstrated a signiﬁcant positive association between amounts of non-
mycobacterial bacterial DNA and minor variant frequencies in a subset of the mapped
genome: signiﬁcant increases, of more than 1.5-fold, were observed in 242/8,006
regions examined, which together cover about 5% of the M. tuberculosis genome.
Although the emphasis of this work was on relatedness between isolates, it is notable
that included within the 242 regions are a series of genes encoding ribosomal com-
ponents (rrs, rrl, rpoB, rpsL, and rpsA) which correspond to major antituberculosis drug
resistance genes (26). Therefore, studies investigating resistance or heteroresistance
using these loci should report estimates of the impact of the presence of nonmyco-
bacterial bacterial DNA on heteroresistance estimates. Such interference may be par-
ticularly marked when direct-from-sample short-read sequencing is used (30), given the
increased ratio of nonmycobacterial to mycobacterial DNA in the absence of selective
mycobacterial ampliﬁcation using culture.
Among these 242 regions, we identiﬁed four “high-variation” regions in which minor
variant frequencies are very strongly inﬂuenced by nonmycobacterial bacterial DNA quan-
tities, with fold increases in minor variant frequencies of 5 in the presence of 20%
nonmycobacterial bacterial DNA. Importantly, if nonmycobacterial bacterial DNA concen-
trations are low (1% of bacterial DNA present), as occurred in retrospective studies when
mycobacteria were subcultured on Lowenstein-Jensen slopes prior to sequencing, in-
creased variation is not observed in these regions. The exclusion of the four high-variation
regions from base calling by a clinically deployedM. tuberculosis pipeline markedly reduced
reported variation between samples derived from the same patient in a short period. In
particular, prior to exclusion of the four high-variation regions, in a test set derived from 234
individuals, 5.2% of intrapatient pairs examined differed by 5 SNVs or more, with the
majority of SNV differences observed in these pairs being 20. Multiple studies indicate
that this is biologically implausible (3, 5, 7), and after exclusion of the four high-variation
regions, comprising only 0.2% of the genome, no pairs had variation of 5 SNVs or more. This
suggests that when using standard masking and DNA extraction from liquid media,
false-positive variation is reported in a small number of sites in a nonmycobacterial bacterial
DNA-dependent manner. Put alternatively, nonmycobacterial bacterial DNA acts as an
interfering substance (20) for relatedness measurements.
A potential limitation of this work is that this approach studies prespeciﬁed
regions of the genome, speciﬁcally coding regions and intergenic regions. This
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approach was chosen to avoid the challenges of analyzing the 4.4  106 bases of
the M. tuberculosis genome individually, with a concomitant loss of statistical
power. Therefore, as described the method may neither detect nor allow selective
masking of small regions with high minor variant frequencies within genes. A
second limitation is that we did not use metagenomics classiﬁers, such as Kraken,
to identify nonmycobacterial interfering DNA and eliminate it prior to mapping to
the M. tuberculosis genome. We did not do this because we observed that for the
highly conserved rrs genes, metagenomic classiﬁers cannot conﬁdently assign reads
to a genus level, likely because there is insufﬁcient sequence variation within
short-read sequencing of rrs to allow this. Therefore, until longer-read sequencing
becomes available, sequencing less conserved ﬂanking genomic regions, a strategy
of read removal based on metagenomics classiﬁcation, will eliminate a high pro-
portion of bona ﬁde M. tuberculosis-derived reads in conserved genes, even in
samples without any nonmycobacterial bacterial DNA. Despite these limitations, the
strategy chosen appears to be of use clinically, based on the reduction in likely
false-positive variation between serial samples from individuals.
The routine clinical of use of next-generation sequencing is rapidly increasing (1,
4, 22). However, the reporting of microbial identity, resistotyping, and relatedness
information requires complex, multistep processes whose outputs are dependent
on specimen decolonization, selective culture, DNA extraction, library construction,
DNA sequencing, and bioinformatics analysis (4). Reagent batches, software ver-
sions, and equipment involved in the process are all subject to change over time.
The adaptive-masking approach we describe here represents a route to quantitative
monitoring of the performance of the output of this pathway, identifying whether
changes in process which may appear innocuous alter mapping and base calling
across the genome. We do not propose that the output from the adaptive-masking
process as demonstrated here with data generated by Public Health England and
processed by particular bioinformatics tools should be used to generate a list of
problematic genomic regions which can be universally applied. Rather, we envisage
that the adaptive-masking process will be performed as part of the acceptance of
process change, and periodically as part of quality monitoring, under the exact
conditions used in the clinical laboratory issuing NGS-based results. A list of
problematic positions to be ignored during relatedness calculations can then be fed
into systems doing such calculations, such as ﬁndNeighbour2 (27), which would
apply such masking across all samples.
Generalizable to other organisms and mapping pipelines, the adaptive-masking
approach we describe here will have application in monitoring the performance of such
processes quantitatively, in interpreting estimates of possible heteroresistance, and in
preventing the calling of false-positive variation in the context of clinically deployed
genomics.
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